March 31, 2021 View Now: 2021 PSTC Virtual Workshop—March 31, 2021 The Predictive Safety Testing Consortium (PSTC) launched its 15th anniversary celebration with a virtual public workshop. Scientis
February 17, 2021 WEBINAR: eCOA: Getting Better Together Initiative – An Update from C-Path’s PRO Consortium and ePRO Consortium This webinar was hosted by the DIA Study Endpoints Community and presented jointly by the PRO Consortium and ePRO Consortium. Date
February 9, 2021-February 10, 2021 SHIP-MD 2021 Virtual Workshop Join Us February 9th, 10th, 11th 2021 Free Public Virtual Meeting and Workshop All stakeholders interested in pediatric medical de
January 21, 2021-February 9, 2024 Watch now: RDCA-DAP and EATRIS Present Rare Disease Drug Develoment Webinar January 21, 2021 | 5:00 p.m. – 6:30 p.m. CET Data Sharing and Analysis to Support Rare Disease Drug Development The Europ
December 2, 2020 COVID-19: Risk Assessment and Mitigation Strategies for the Collection of PRO Data through Clinical Sites – Lessons Learned This webinar provides an update from sponsors and eCOA providers as they discuss lessons learned from managing clinical trials tha
October 27, 2020 Critical Path for Alzheimer’s Disease 2020 Annual Meeting and Regulatory Science Workshop – Virtual October 27, 2020 9:30 a.m. – 1:00 p.m. (US Eastern Time) The Critical Path for Alzheimer’s Disease (CPAD) is a Critical Path I
October 19, 2020 Watch Now: RDCA-DAP 2020 Virtual Workshop Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about: RDCA-D
October 10, 2020 Watch Now: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis Webinar Despite increasing numbers of drug targets and technologies, rare disease drug development is frequently slowed by t
September 13, 2020 The Critical Path Institute: 15 Years of Impact A catalyst in the development of new tools and approaches to advance regulatory science and medical product developm
September 13, 2020 Drug Development and Regulation in the Age of Precision Medicine An introduction and overview of the Critical Path Institute and University of Arizona collaboration and the regulatory sci
